Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
421 to 440 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| R24OD011883 | The Monarch Initiative: Linking Diseases to Model Organism Resources | 2 | 2024 |
| U01AG068221 | Assessing Alzheimer disease risk and heterogeneity using multimodal machine learning approaches | 2 | 2024 |
| U24OD023121 | Precision Medicine Initiative Cohort Program Biobank | 2 | 2024 |
| UL1TR001425 | Center for Clinical and Translational Science and Training | 2 | 2024 |
| UL1TR001427 | Together: Transforming and Translating Discovery to Improve Health | 2 | 2024 |
| DP5OD029630 | Investigating the contribution of non-coding genetic variation to rare disorders | 1 | 2024 |
| F30HL156669 | Genome Editing Treatment for Catecholaminergic Polymorphic Ventricular Tachycardia | 1 | 2024 |
| F31HL164060 | Mechanisms of cardiomyocyte dysfunction due to the E258K-MYBPC3 mutation modeled in patient-derived cardiomyocytes | 1 | 2024 |
| F32HL164108 | Dissecting the mechanisms of how MYH7 S2 mutations lead to genetic hypertrophic cardiomyopathy | 1 | 2024 |
| IK2BX004642 | Dissecting the mechanism of how dominant negative MYH7 mutations lead to genetic cardiomyopathies | 1 | 2024 |
| K08HL148508 | "SHROOM3 is a Novel Cause of Congenital Heart Disease" | 1 | 2024 |
| K08HL148540 | Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes | 1 | 2024 |
| K23HL150322 | Role of DNA methylation in cardiac failure and recovery | 1 | 2024 |
| K24HL150630 | Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum | 1 | 2024 |
| K24HL153669 | Mentoring in Patient-Oriented and Translational HFpEF Research | 1 | 2024 |
| K25HL148386 | Injectable Carbon Nanotube-Functionalized Hydrogel for miRNA Delivery | 1 | 2024 |
| K99HL166773 | Parallel Characterization of Genetic Variants in Chemotherapy-Induced Cardiotoxicity Using iPSCs | 1 | 2024 |
| P30AG068345 | The University of Southern California and Buck Institute Nathan Shock Center | 1 | 2024 |
| P30ES000002 | Harvard Chan School NIEHS Center for Environmental Health | 1 | 2024 |
| P50HD087351 | Myoediting of Duchenne Muscular Dystrophy | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=22